Global, Regional, and National Burden of Acute Lymphoblastic Leukemia in Children: Epidemiological Trends Analysis from 1990 to 2021

Overview

Journal iScience

Publisher Cell Press

Date 2024 Dec 24

PMID 39717082

Authors

Yuyuan Hu

Yongping Liu

Jieting Fu

Yong Liu

Haiying Wang

Ying Song

Affiliations

Soon will be listed here.

Abstract

Children are the main susceptible group to acute lymphoblastic leukemia (ALL), and the lack of sufficient data has impeded a comprehensive understanding of its global impact. This study analyzed the annual numbers and rates of incidence, deaths, and disability-adjusted life years (DALYs) of childhood ALL from 1990 to 2021, disaggregated by age group, gender, and socio-demographic index (SDI) at the global, regional, and national levels, based on the 2021 Global Burden of Disease (GBD) database. Although global deaths and DALYs rates for childhood ALL showed declining trends, the incidence rate fluctuated. Incidence rates in high SDI regions were higher, but deaths and DALY rates were lower. Moreover, the burden in Sub-Saharan Africa and other low SDI countries was growing. The burden on boys has been higher than on girls in this period. This study underscored improving prevention and treatment measures are critical to control the persistent global burden of children ALL.

References

Petridou E, Sergentanis T, Perlepe C, Papathoma P, Tsilimidos G, Kontogeorgi E . Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis. Ann Oncol. 2014; 26(3):589-97. DOI: 10.1093/annonc/mdu572. View

. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403(10440):2204-2256. PMC: 11121021. DOI: 10.1016/S0140-6736(24)00685-8. View

Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y . Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020; 9:14. PMC: 7304189. DOI: 10.1186/s40164-020-00170-6. View

Schuz J, Erdmann F . Environmental Exposure and Risk of Childhood Leukemia: An Overview. Arch Med Res. 2017; 47(8):607-614. DOI: 10.1016/j.arcmed.2016.11.017. View

Reismuller B, Attarbaschi A, Peters C, Dworzak M, Potschger U, Urban C . Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Br J Haematol. 2008; 144(4):559-70. DOI: 10.1111/j.1365-2141.2008.07499.x. View

. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2021; 23(1):27-52. PMC: 8716339. DOI: 10.1016/S1470-2045(21)00581-7. View

Dixon S, Chen Y, Yasui Y, Pui C, Hunger S, Silverman L . Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2020; 38(29):3418-3429. PMC: 7527155. DOI: 10.1200/JCO.20.00493. View

Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G . Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023; 13(1):82. PMC: 10188596. DOI: 10.1038/s41408-023-00853-3. View

Newman H, Li Y, Liu H, Myers R, Tam V, DiNofia A . Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. Blood. 2022; 141(6):609-619. PMC: 9979709. DOI: 10.1182/blood.2022017866. View

10.

Pui C, Yang J, Hunger S, Pieters R, Schrappe M, Biondi A . Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol. 2015; 33(27):2938-48. PMC: 4567699. DOI: 10.1200/JCO.2014.59.1636. View

11.

Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019; 5(12):1749-1768. PMC: 6777271. DOI: 10.1001/jamaoncol.2019.2996. View

12.

. The burden of neurological conditions in north Africa and the Middle East, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Glob Health. 2024; 12(6):e960-e982. PMC: 11099299. DOI: 10.1016/S2214-109X(24)00093-7. View

13.

Anandasabapathy S, Asirwa C, Grover S, Mungo C . Cancer burden in low-income and middle-income countries. Nat Rev Cancer. 2024; 24(3):167-170. DOI: 10.1038/s41568-023-00659-2. View

14.

Barz M, Hof J, Groeneveld-Krentz S, Loh J, Szymansky A, Astrahantseff K . Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia. Blood. 2020; 135(12):921-933. PMC: 7218751. DOI: 10.1182/blood.2019002499. View

15.

Ward E, DeSantis C, Robbins A, Kohler B, Jemal A . Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):83-103. DOI: 10.3322/caac.21219. View

16.

. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

17.

Tran T, Hunger S . The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Semin Cancer Biol. 2020; 84:144-152. DOI: 10.1016/j.semcancer.2020.10.013. View

18.

Desai A, Mohammed T, Duma N, Garassino M, Hicks L, Kuderer N . COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response. JAMA Oncol. 2021; 7(12):1882-1890. PMC: 8805603. DOI: 10.1001/jamaoncol.2021.4083. View

19.

Brivio E, Bautista F, Zwaan C . Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia. Haematologica. 2024; 109(6):1700-1712. PMC: 11141655. DOI: 10.3324/haematol.2023.283815. View

20.

Francis S, Wallace A, Wendt G, Li L, Liu F, Riley L . In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood. 2016; 129(12):1680-1684. PMC: 5364339. DOI: 10.1182/blood-2016-07-723148. View